Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions https://www.biorxiv.org/content/10.1101/2023.07.25.550460v1?med=mas
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions https://www.biorxiv.org/content/10.1101/2023.07.25.550460v1?med=mas